
Mercedes-Benz Unveils Advanced Virtual Assistant With AI Capabilities
Jan 09, 2024 10:18 am UTC| Business Technology
Mercedes-Benz introduced a groundbreaking virtual assistant during the CES electronics trade fair, showcasing the increasing integration of artificial intelligence in the automotive industry. This state-of-the-art...

OpenAI Says The New York Times Copyright Lawsuit is Baseless
Jan 09, 2024 10:12 am UTC| Business Technology
The New York Times previously sued OpenAI, an American artificial intelligence research organization, for alleged copyright infringement. The lawsuit was filed by the news publishing company last month, and OpenAI finally...

Lululemon, Abercrombie & Fitch Raise Forecasts for Strong Holiday Quarter
Jan 09, 2024 09:21 am UTC| Business
Lululemon and Abercrombie Fitch have raised their holiday quarter forecasts, suggesting robust demand during the crucial sales period. This comes after a mixed holiday season for the retail sector, with retailers vying...

Merck, Harpoon Therapeutics Agree to $680M Merger Deal
Jan 09, 2024 09:16 am UTC| Business
Merck Co. disclosed its merger deal with Harpoon Therapeutics Inc. on Monday, Jan. 8. The total equity value of the acquisition agreement is $680 million. Details of the Definitive Agreement As per Reuters, the...

Microsoft, Qcells Sign Strategic Deal for Solar Panel Supply
Jan 09, 2024 08:17 am UTC| Business
Microsoft Corporation and Qcells struck a new deal for the supply of solar panels. The strategic alliance will see the South Korean energy solutions firm providing the American tech firm with 12-gigawatts US-made solar...

ByteDance in Talks to Sell Gaming Assets, Including Nuverse, to Tencent
Jan 09, 2024 08:08 am UTC| Business Technology
ByteDance, the parent company of popular social media platform TikTok, is currently in discussions with multiple potential buyers for its gaming assets, including Tencent, the worlds largest video game company. This...

Johnson & Johnson Acquires Ambrx Biopharma for $2B
Jan 09, 2024 07:58 am UTC| Business
Johnson Johnson confirmed on Monday, Jan. 8, that it is buying Ambrx cancer treatment developer Ambrx Biopharma for $2 billion. It will be paid in cash, and this acquisition deal comes as the company seeks to fill in a...
China Signals Subtle Treasury Pullback: Banks Urged to Ease US Debt Exposure
China Signals Quiet Treasury Trim: Banks Told to Ease Up on US Debt
The “Takaichi Trade”: How Japan’s First Female PM Is Shaping the Yen
How the US–India tariff truce boosts major Indian industries, Surat to Pharma